Adjuvant Therapy of Completely Resected Merkel Cell Carcinoma With Immune Checkpoint Blocking Antibodies vs Observation
Clinical trial NCT02196961 · COMPLETED
Trial details
- NCT number
- NCT02196961
- Sponsor
- Prof. Dr. med. Dirk Schadendorf
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2024-08-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.